Case Over Skelaxin 'Sham' IP Suits Heads To State Court

Law360, New York (May 20, 2014, 7:52 PM EDT) -- A Tennessee federal judge ruled Tuesday that BlueCross BlueShield of Tennessee Inc.'s case accusing a Pfizer Inc. unit and Mutual Pharmaceutical Co. of colluding to block generic versions of the muscle relaxant Skelaxin with baseless patent suits didn't present substantial federal issues, sending the case to state court.

U.S. District Judge Curtis L. Collier approved a motion from BlueCross to carve its case against Mutual and Pfizer's King Pharmaceuticals Inc. out of the vast multidistrict litigation underway in his court after finding that the original state...
To view the full article, register now.